Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types
Abstract Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56+ NK cells, and CD4+ and CD8+ T…
Abstract Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56+ NK cells, and CD4+ and CD8+ T…
Abstract Objective: To investigate the prognostic value of the co-chaperone protein DnaJ Heat Shock Protein Family (Hsp40) Member B11 (DNAJB11)…
Abstract In response to the need of more rigorous data on medical cannabis and chronic pain, we conducted a 3-month…
Abstract Background: Little is known about the clinical training or practice experiences among physicians who certify patients for medical marijuana.…
Abstract CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6) reportedly stabilizes programmed death-ligand 1 (PD-L1) and enhances the efficacy of immunotherapy. However,…
Abstract Background: Glutamine and glutamate are known to play important roles in cancer biology. However, no detailed information is available…
Abstract Thyroid-carcinoma (THCA) is the most common malignancy with an increasing incidence. Recent evidence has emphasized the role of microRNA…